HDFC Bank vs Bristol-Myers Squibb Company
Comparação do valor de mercado ao longo do tempo
HDFC Bank
$133.7B
Posição #127
Bristol-Myers Squibb Company
$134.9B
Posição #125
Valor de mercado ao longo do tempo
Momentos-chave
- HDFC Bank ultrapassou Bristol-Myers Squibb Company até 2018
- Bristol-Myers Squibb Company ultrapassou HDFC Bank até 2026
Comparação ano a ano
| Ano | HDFC Bank | Bristol-Myers Squibb Company | LÃder |
|---|---|---|---|
| 2026 | $133.7B | $134.9B | Bristol-Myers Squibb Company |
| 2025 | $183.1B | $107.8B | HDFC Bank |
| 2024 | $161.6B | $107.6B | HDFC Bank |
| 2023 | $153.7B | $92.9B | HDFC Bank |
| 2022 | $144.8B | $125.8B | HDFC Bank |
| 2021 | $130.0B | $105.8B | HDFC Bank |
| 2020 | $125.7B | $102.0B | HDFC Bank |
| 2019 | $111.3B | $102.4B | HDFC Bank |
| 2018 | $92.1B | $80.2B | HDFC Bank |
| 2017 | $80.7B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $51.7B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $46.0B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $40.1B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $27.8B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $28.1B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $17.6B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $19.2B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $13.8B | $28.9B | Bristol-Myers Squibb Company |
| 2008 | $8.1B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $13.9B | $27.1B | Bristol-Myers Squibb Company |
| 2006 | $8.5B | $25.9B | Bristol-Myers Squibb Company |
| 2005 | $5.6B | $21.6B | Bristol-Myers Squibb Company |
| 2004 | $4.1B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $2.8B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $1.7B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $1.7B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $1.7B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $1.2B | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $401.7M | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $581.3M | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $279.5M | $18.8B | Bristol-Myers Squibb Company |